ASCO Releases New Guidelines on PARP Inhibitor Use for Management of Ovarian Cancer
September 1, 2020 2:00 pmBy Hannah Slater
The recommendations were based on a review of 17 clinical trials, FDA approvals, and consensus where evidence was lacking.
The American Society for Clinical Oncology (ASCO) published new guidelines on the use of PARP inhibitors in the … Read more